Live Breaking News & Updates on Sbio inc

Stay informed with the latest breaking news from Sbio inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sbio inc and stay connected to the pulse of your community

CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates

SUZHOU, China, March 27, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research,

China , United-states , Thailand , United-kingdom , Singapore , London , City-of , Taiwan , Australia , Macau , Hong-kong , Suzhou

Short Interest in 3SBio Inc. (OTCMKTS:TRSBF) Expands By 444.4%

Short Interest in 3SBio Inc. (OTCMKTS:TRSBF) Expands By 444.4%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

China , Sbio-inc , Sbio-company-profile , Get-free-report , Mainland-china ,

Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances

/PRNewswire/ -- The "Biosimilar Monoclonal Antibodies Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The expansion of the...

Dublin , Ireland , United-states , America , Laura-wood , Coherus-biosciences , Mabpharm-limitied , Aprogen-biologics , Reliance-life-sciences , Xentria-inc , Qilu-pharmaceutical-co , Office-hours-call

Innovent Announces Retirement of CFO and Appointment of New CFO

ROCKVILLE, Md. and SUZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high quality...

Macau , Hong-kong , United-states , Jinxin , Zhejiang , China , Taiwan , Suzhou , Jiangsu , Michael-yu , Innovent-biologics , Adimab-incyte

3SBio Inc. (OTCMKTS:TRSBF) Sees Significant Growth in Short Interest

3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 574,000 shares, a growth of 57,300.0% from the December 15th total of 1,000 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is […]

China , Sbio-inc , Get-free-report , Mainland-china , 3sbio , Otcmkts-trsbf , Trsbf , Medical , Stocks , Options , Put

Global Immunology Market Soars with Projected $56.07

Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The

Dublin , Ireland , United-states , America , Eli-lilly , Merck-kga , Pfizer-inc , Antares-pharma-inc , Immunext-inc , Glaxosmithkline-plc , Bristol-myers-squibb-co , Mitsubishi-chemical-group-corp

CStone Announces Strategic Partnership and Exclusive Licensing Agreement with 3SBio for Nofazinlimab (Anti-PD-1 Antibody) in Mainland China

SUZHOU, China, Nov. 1, 2023 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research,

China , United-kingdom , Shenyang , Liaoning , Lou-jing , Fujian , Suzhou , Jiangsu , Thailand , United-states , British , American

Global Darbepoetin Alfa (Aranesp) Market Report 2023-2027 & 2032: Darbepoetin Alfa Market Offers a Range of Products, Including Aranesp and More

/PRNewswire/ -- The "Darbepoetin Alfa (Aranesp) Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global darbepoetin...

India , Dong-co , Xizang , China , Canada , Italy , France , South-korea , Australia , Germany , Indonesia , United-states

Global $5.56 Bn Darbepoetin Alfa (Epogen, Procrit, Aranesp) Market Analysis & Forecasts, 2017-2022, 2022-2027F, 2032F

Global Darbepoetin Alfa (Aranesp) Market Global Darbepoetin Alfa (Aranesp) Market Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Darbepoetin Alfa (Aranesp) Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global darbepoetin alfa (Aranesp) market is expected to grow from $5.25 billion in 2022 to $5.56 billion in 2023 at a compound annual growth rate (CAGR) of 6%. The darbepoetin alfa (Aranesp) market is expected to reach $6.73 billion in 2027 at a CAGR of

Canada , South-korea , Indonesia , Australia , Brazil , France , Ukraine , India , China , Germany , United-states , Dong-co

Global $5.56 Bn Darbepoetin Alfa (Epogen, Procrit, Aranesp)

Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The

Canada , Russia , France , Spain , United-kingdom , China , Ukraine , Italy , India , South-korea , Intas , Bahia